IE
IE · IE · IE-PA-EU/1/24/1897/001
Emcitate 350 microgram dispersible tablets
ATC H03AA04
Last synced from HPRA (Ireland) on
Identification
ManufacturerRare Thyroid Therapeutics International AB
CountryIE (IE)
ATC codeH03AA04
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/24/1897/001
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Dispersible tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"H03AA04"
],
"strength": null,
"pa_number": "EU/1/24/1897/001",
"substances": [
"Tiratricol"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "12/02/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code H03AA04.
- ISEmcitateRare Thyroid Therapeutics International AB
- DKEmcitateRare Thyroid Therapeutics International AB
- PLEmcitateRare Thyroid Therapeutics International AB
- NOEmcitateRare Thyroid Therapeutics
- FIEmcitateRare Thyroid Therapeutics International AB
- CZEMCITATERare Thyroid Therapeutics International AB, Stockholm
- NLEmcitate 350 microgram dispergeerbare tablettenRare Thyroid Therapeutics International AB
- BEEmcitate 350 µgRare Thyroid Therapeutics International
Access this data programmatically
Query Emcitate 350 microgram dispersible tablets and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.